LEXINGTON, Mass.--(BUSINESS WIRE)--Concert Pharmaceuticals, Inc. (NASDAQ: CNCE) today announced that it will report its financial results for the year ended December 31, 2015, on Tuesday, March 1, 2016, before the U.S. financial markets open. The Company will host a conference call and webcast at 8:30 a.m. ET to discuss 2015 financial results and provide a business update. The Company will also discuss results from Part 1 of an ongoing Phase 1 trial comparing a single-dose tablet formulation of CTP-656 to the commercial tablet formulation of Kalydeco® (ivacaftor). Individuals interested in participating in the call should dial (855) 354-1855 (U.S. and Canada) or (484) 365-2865 (International).
